Glenmark’s arm Ichnos Sciences enters pact with Almirall Agreement for First-IN-Class IL-1RAP Antagonist Monoclonal Antibody.
Synopsis- Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with…